Not recruiting
Rapid eye movement sleep behaviour disorder
Not recruitingStudy on the Effects and Safety of Piromelatine for Patients with Idiopathic Rapid Eye Movement Behavior Disorder (iRBD)
InvestigationalNo placebo
Study on the Effects and Safety of Piromelatine for Patients with Idiopathic Rapid Eye Movement Behavior Disorder (iRBD)
InvestigationalNo placebo
- Disease:Rapid eye movement sleep behaviour disorder
- Substances:Piromelatine
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Piromelatine